SEC Form 4 · accession 0001209191-15-086459
Vanda Pharmaceuticals Inc. · VNDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth Bate
Director
Period of report
Dec 17, 2015
Accepted (ET)
Dec 21, 2015 · 6:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001347178
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $9.38 | Dec 17, 2015 | A | 35,000 | A | — | Dec 17, 2025 | Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F1Exercisable in equal monthly installments over 48 months beginning on December 17, 2015, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.